Recent advances in metal nanoparticles in cancer therapy

References

• Conde J, Doria G, Baptista P. Noble metal nanoparticles applications in cancer. J Drug Deliv. 2012;2012:751075.
   PubMedGoogle Scholar
• Vinardell MP, Mitjans M. Antitumor activities of metal oxide nanoparticles. Nanomaterials. 2015;5:1004–1021.
   Web of Science ®Google Scholar
• Stewart B, Wild CP. World cancer report 2014. Geneva: WHO Press; 2014.
   Google Scholar
• Sutradhar KB, Amin ML. Nanotechnology in cancer drug delivery and selective targeting. ISRN Nanotechnol. 2014;2014:939378.
   Google Scholar
• Zhao G, Rodriguez BL. Molecular targeting of liposomal nanoparticles to tumor microenvironment. Int J Nanomed. 2013;8:61–71.
   PubMed Web of Science ®Google Scholar
• Nguyen KT. Targeted nanoparticles for cancer therapy: promises and challenge. OMICS Publishing Group; 2011.
   Google Scholar
• Coates A, Abraham S, Kaye SB, et al. On the receiving end—patient perception of the side-effects of cancer chemotherapy. Eur J Cancer Clin Oncol. 1983;19:203–208.
   PubMedGoogle Scholar
• Narvekar M, Xue HY, Eoh JY, et al. Nanocarrier for poorly water-soluble anticancer drugs—barriers of translation and solutions. AAPS PharmSciTech. 2014;15:822–833.
   PubMed Web of Science ®Google Scholar
• Choi I-K, Strauss R, Richter M, et al. Strategies to increase drug penetration in solid tumors, Front. Oncol. 2013;3:193.
   PubMedGoogle Scholar
• Sack M, Alili L, Karaman E, et al. Combination of conventional chemotherapeutics with redox-active cerium oxide nanoparticles—a novel aspect in cancer therapy. Mol Cancer Ther. 2014;13:1740–1749.
   PubMed Web of Science ®Google Scholar
• Kumari M, Singh SP, Chinde S, et al. Toxicity study of cerium oxide nanoparticles in human neuroblastoma cells. Int J Toxicol. 2014;33:86–97.
   PubMed Web of Science ®Google Scholar
• Sahoo S, Parveen S, Panda J. The present and future of nanotechnology in human health care. Nanomed: Nanotechnol Biol Med. 2007;3:20–31.
   PubMed Web of Science ®Google Scholar
• Peer D, Karp JM, Hong S, et al. Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol. 2007;2:751–760.
   PubMed Web of Science ®Google Scholar
• Florence AT. “Targeting” nanoparticles: the constraints of physical laws and physical barriers. J Control Release. 2012;164:115–124.
   PubMed Web of Science ®Google Scholar
• Selvan ST, Tan TTY, Yi DK, et al. Functional and multifunctional nanoparticles for bioimaging and biosensing. Langmuir. 2010;26:11631–11641.
   PubMed Web of Science ®Google Scholar
• Baptista P, Pereira E, Eaton P, et al. Gold nanoparticles for the development of clinical diagnosis methods. Anal Bioanal Chem. 2008;391:943–950.
   PubMed Web of Science ®Google Scholar
• Huang X, Jain PK, El-Sayed IH, et al. Gold nanoparticles: interesting optical properties and recent applications in cancer diagnostics and therapy. Nanomedicine. 2007;2:681–693.
   PubMed Web of Science ®Google Scholar
• Hainfeld JF, Slatkin DN, Smilowitz HM. The use of gold nanoparticles to enhance radiotherapy in mice. Phys Med Biol. 2004;49:N309.
   PubMed Web of Science ®Google Scholar
• Hainfeld JF, Dilmanian FA, Slatkin DN, et al. Radiotherapy enhancement with gold nanoparticles. J Pharm Pharmacol. 2008;60:977–985.
   PubMed Web of Science ®Google Scholar
• Yavuz MS, Cheng Y, Chen J, et al. Gold nanocages covered by smart polymers for controlled release with near-infrared light. Nat Mater. 2009;8:935–939.
   PubMed Web of Science ®Google Scholar
• Han G, Ghosh P, Rotello VM. Multi-functional gold nanoparticles for drug delivery. Bio-applications of nanoparticles. Brooklyn (NY): Springer; 2007. p. 48–56.
   Google Scholar
• Jones MR, Millstone JE, Giljohann DA, et al. Plasmonically controlled nucleic acid dehybridization with gold nanoprisms. ChemPhysChem. 2009;10:1461–1465.
   PubMed Web of Science ®Google Scholar
• Nishiyama N. Nanomedicine: nanocarriers shape up for long life. Nat Nanotechnol. 2007;2:203.
   PubMed Web of Science ®Google Scholar
• Sau TK, Rogach AL, Jäckel F, et al. Properties and applications of colloidal nonspherical noble metal nanoparticles. Adv Mater. 2010;22:1805–1825.
   PubMed Web of Science ®Google Scholar
• Sperling, RA, Rivera Gil, P, Zhang, F, et al. Biological applications of gold nanoparticles. Chem Soc Rev. 2008;37:1896–1908.
   PubMed Web of Science ®Google Scholar
• Xie J, Lee S, Chen X. Nanoparticle-based theranostic agents. Adv Drug Deliv Rev. 2010;62:1064–1079.
   PubMed Web of Science ®Google Scholar
• Sperling RA, Parak W. Surface modification, functionalization and bioconjugation of colloidal inorganic nanoparticles. Philos Trans R Soc Lond A: Math Phys Eng Sci. 2010;368:1333–1383.
   PubMed Web of Science ®Google Scholar
• Jain PK, Huang X, El-Sayed IH, et al. Noble metals on the nanoscale: optical and photothermal properties and some applications in imaging, sensing, biology, and medicine. Acc Chem Res. 2008;41:1578–1586.
   PubMed Web of Science ®Google Scholar
• Lee K-S, El-Sayed MA. Gold and silver nanoparticles in sensing and imaging: sensitivity of plasmon response to size, shape, and metal composition. J Phys Chem B. 2006;110:19220–19225.
   PubMed Web of Science ®Google Scholar
• Chen H, Shao L, Ming T, et al. Understanding the photothermal conversion efficiency of gold nanocrystals. Small. 2010;6:2272–2280.
   PubMed Web of Science ®Google Scholar
• Day ES, Morton JG, West JL. Nanoparticles for thermal cancer therapy. J Biomech Eng. 2009;131:074001.
   PubMed Web of Science ®Google Scholar
• Liu Y, Miyoshi H, Nakamura M. Nanomedicine for drug delivery and imaging: a promising avenue for cancer therapy and diagnosis using targeted functional nanoparticles. Int J Cancer. 2007;120:2527–2537.
   PubMed Web of Science ®Google Scholar
• Caputo F, De Nicola M, Ghibelli L. Pharmacological potential of bioactive engineered nanomaterials. Biochem Pharmacol. 2014;92:112–130.
   PubMed Web of Science ®Google Scholar
• Powell AC, Paciotti GF, Libutti SK. Colloidal gold: a novel nanoparticle for targeted cancer therapeutics. Methods Mol Biol. 2010;624:375–384.
   PubMedGoogle Scholar
• Porcel E, Liehn S, Remita H, et al. Platinum nanoparticles: a promising material for future cancer therapy? Nanotechnology. 2010;21:85103.
   PubMed Web of Science ®Google Scholar
• Danhier F, Feron O, Préat V. To exploit the tumor microenvironment: passive and active tumor targeting of nanocarriers for anti-cancer drug delivery. J Control Release. 2010;148:135–146.
   PubMed Web of Science ®Google Scholar
• Ferrari M. Cancer nanotechnology: opportunities and challenges. Nat Rev Cancer. 2005;5:161–171.
   PubMed Web of Science ®Google Scholar
• Gil PR, Parak WJ. Composite nanoparticles take aim at cancer. ACS Nano. 2008;2:2200–2205.
   PubMed Web of Science ®Google Scholar
• Minelli C, Lowe SB, Stevens MM. Engineering nanocomposite materials for cancer therapy. Small. 2010;6:2336–2357.
   PubMed Web of Science ®Google Scholar
• Dinarvand R, Cesar de Morais P, D’Emanuele A. Nanoparticles for targeted delivery of active agents against tumor cells. J Drug Deliv. 2012;2012:528123.
   PubMedGoogle Scholar
• Bernardi RJ, Lowery AR, Thompson PA, et al. Immunonanoshells for targeted photothermal ablation in medulloblastoma and glioma: an in vitro evaluation using human cell lines. J Neurooncol. 2008;86:165–172.
   PubMed Web of Science ®Google Scholar
• Fichou Y, Férec C. The potential of oligonucleotides for therapeutic applications. Trends Biotechnol. 2006;24:563–570.
   PubMed Web of Science ®Google Scholar
• Toub N, Malvy C, Fattal E, et al. Innovative nanotechnologies for the delivery of oligonucleotides and siRNA. Biomed Pharmacother. 2006;60:607–620.
   PubMed Web of Science ®Google Scholar
• Fire A, Xu S, Montgomery MK, et al. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature. 1998;391:806–811.
   PubMed Web of Science ®Google Scholar
• Baker M. RNA interference: from tools to therapies. Nature. 2010;464:1225.
   Web of Science ®Google Scholar
• Milhavet O, Gary DS, Mattson MP. RNA interference in biology and medicine. Pharmacol Rev. 2003;55:629–648.
   PubMed Web of Science ®Google Scholar
• Wall NR, Yang S. Small RNA: can RNA interference be exploited for therapy? Lancet. 2003;362:1401.
   PubMed Web of Science ®Google Scholar
• Hannon GJ, Rossi JJ. Unlocking the potential of the human genome with RNA interference. Nature. 2004;431:371–378.
   PubMed Web of Science ®Google Scholar
• Braun GB, Pallaoro A, Wu G, et al. Laser-activated gene silencing via gold nanoshell–siRNA conjugates. ACS Nano. 2009;3:2007–2015.
   PubMed Web of Science ®Google Scholar
• Giljohann DA, Seferos DS, Prigodich AE, et al. Gene regulation with polyvalent siRNA–nanoparticle conjugates. J Am Chem Soc. 2009;131:2072–2073.
   PubMed Web of Science ®Google Scholar
• Whitehead KA, Langer R, Anderson DG. Knocking down barriers: advances in siRNA delivery. Nat Rev Drug Discov. 2009;8:129–138.
   PubMed Web of Science ®Google Scholar
• Lee J-S, Green JJ, Love KT, et al. Gold, poly(beta-amino ester) nanoparticles for small interfering RNA delivery. Nano Lett. 2009;9:2402–2406.
   PubMed Web of Science ®Google Scholar
• Lellouche E, Israel LL, Bechor M, et al. MagRET nanoparticles: an iron oxide nanocomposite platform for gene silencing from MicroRNAs to long noncoding RNAs. Bioconjugate Chem. 2015;26:1692–1701.
   PubMed Web of Science ®Google Scholar
• Castillo B, Bromberg L, López X, et al. Intracellular delivery of siRNA by polycationic superparamagnetic nanoparticles. J Drug Deliv. 2012;2012:218940.
   PubMedGoogle Scholar
• Guo J, O’Driscoll CM, Holmes JD, et al. Bioconjugated gold nanoparticles enhance cellular uptake: a proof of concept study for siRNA delivery in prostate cancer cells. Int J Pharm. 2016;509:16–27.
   PubMed Web of Science ®Google Scholar
• Conde J, Ambrosone A, Sanz V, et al. Design of multifunctional gold nanoparticles for in vitro and in vivo gene silencing. ACS Nano. 2012;6:8316–8324.
   PubMed Web of Science ®Google Scholar
• Baptista PV. Cancer nanotechnology-prospects for cancer diagnostics and therapy. CCTR. 2009;5:80–88.
   Google Scholar
• Su X-Y, Liu PD, Wu H, et al. Enhancement of radiosensitization by metal-based nanoparticles in cancer radiation therapy. Cancer Biol Med. 2014;11:86–91.
   PubMedGoogle Scholar
• Chang MY, Shiau AL, Chen YH, et al. Increased apoptotic potential and dose‐enhancing effect of gold nanoparticles in combination with single‐dose clinical electron beams on tumor‐bearing mice. Cancer Sci. 2008;99:1479–1484.
   PubMed Web of Science ®Google Scholar
• Zhang XD, Wu D, Shen X, et al. Size-dependent radiosensitization of PEG-coated gold nanoparticles for cancer radiation therapy. Biomaterials. 2012;33:6408–6419.
   PubMed Web of Science ®Google Scholar
• Liu P, Huang Z, Chen Z, et al. Silver nanoparticles: a novel radiation sensitizer for glioma? Nanoscale. 2013;5:11829–11836.
   PubMed Web of Science ®Google Scholar
• Ehdaie B. Application of nanotechnology in cancer research: review of progress in the National Cancer Institute's Alliance for Nanotechnology. Int J Biol Sci. 2007;3:108–110.
   PubMed Web of Science ®Google Scholar
• Gibson JD, Khanal BP, Zubarev ER. Paclitaxel-functionalized gold nanoparticles. J Am Chem Soc. 2007;129:11653–11661.
   PubMed Web of Science ®Google Scholar
• Dhar S, Daniel WL, Giljohann DA, et al. Polyvalent oligonucleotide gold nanoparticle conjugates as delivery vehicles for platinum (IV) warheads. J Am Chem Soc. 2009;131:14652–14653.
   PubMed Web of Science ®Google Scholar
• Brown SD, Nativo P, Smith JA, et al. Gold nanoparticles for the improved anticancer drug delivery of the active component of oxaliplatin. J Am Chem Soc. 2010;132:4678–4684.
   PubMed Web of Science ®Google Scholar
• Hackenberg S, Scherzed A, Harnisch W, et al. Antitumor activity of photo-stimulated zinc oxide nanoparticles combined with paclitaxel or cisplatin in HNSCC cell lines. J Photochem Photobiol B: Biol. 2012;114:87–93.
   PubMed Web of Science ®Google Scholar
• Guo D, Wu C, Jiang H, et al. Synergistic cytotoxic effect of different sized ZnO nanoparticles and daunorubicin against leukemia cancer cells under UV irradiation. J Photochem Photobiol B: Biol. 2008;93:119–126.
   PubMed Web of Science ®Google Scholar
• Yang X, Hong H, Grailer JJ, et al. cRGD-functionalized, DOX-conjugated, and 64 Cu-labeled superparamagnetic iron oxide nanoparticles for targeted anticancer drug delivery and PET/MR imaging. Biomaterials. 2011;32:4151–4160.
   PubMed Web of Science ®Google Scholar
• Roemer RB. Engineering aspects of hyperthermia therapy. Annu Rev Biomed Eng. 1999;1:347–376.
   PubMed Web of Science ®Google Scholar
• Milleron R, Bratton S. 'Heated' debates in apoptosis. Cell Mol Life Sci. 2007;64:2329–2333.
   PubMed Web of Science ®Google Scholar
• Curley SA. Radiofrequency ablation of malignant liver tumors. Ann Surg Oncol. 2003;10:338–347.
   PubMed Web of Science ®Google Scholar
• Van der Zee J. Heating the patient: a promising approach? Ann Oncol. 2002;13:1173–1184.
   PubMed Web of Science ®Google Scholar
• Wust P, Hildebrandt B, Sreenivasa G, et al. Hyperthermia in combined treatment of cancer. Lancet Oncol. 2002;3:487–497.
   PubMed Web of Science ®Google Scholar
• Falk M, Issels R. Hyperthermia in oncology. Int J Hyperthermia. 2001;17:1–18.
   PubMed Web of Science ®Google Scholar
• Kapp DS, Hahn GM, Carlson RW. Principles of hyperthermia. Ontario: B.C Decker Inc.; 2000.
   Google Scholar
• Feldman AL, Libutti SK, Pingpank JF, et al. Analysis of factors associated with outcome in patients with malignant peritoneal mesothelioma undergoing surgical debulking and intraperitoneal chemotherapy. JCO. 2003;21:4560–4567.
   PubMed Web of Science ®Google Scholar
• Chang E, Alexander HR, Libutti SK, et al. Laparoscopic continuous hyperthermic peritoneal perfusion. J Am Coll Surg. 2001;193:225–229.
   PubMed Web of Science ®Google Scholar
• Kalambur VS, Longmire EK, Bischof JC. Cellular level loading and heating of superparamagnetic iron oxide nanoparticles. Langmuir. 2007;23:12329–12336.
   PubMed Web of Science ®Google Scholar
• Balivada S, Rachakatla RS, Wang H, et al. A/C magnetic hyperthermia of melanoma mediated by iron (0)/iron oxide core/shell magnetic nanoparticles: a mouse study. BMC Cancer. 2010;10:119.
   PubMed Web of Science ®Google Scholar
• Huang HS, Hainfeld JF. Intravenous magnetic nanoparticle cancer hyperthermia. Int J Nanomed. 2013;8:2521–2532.
   PubMed Web of Science ®Google Scholar
• Shi Kam NW., O'Connell M, Wisdom, JA, et al. Carbon nanotubes as multifunctional biological transporters and near-infrared agents for selective cancer cell destruction. Proc Natl Acad Sci USA. 2005;102:11600–11605.
   PubMed Web of Science ®Google Scholar
• Torti SV, Byrne F, Whelan O, et al. Thermal ablation therapeutics based on CNx multi-walled nanotubes. Int J Nanomed. 2007;2:707.
   PubMed Web of Science ®Google Scholar
• Moon HK, Lee SH, Choi HC. In vivo near-infrared mediated tumor destruction by photothermal effect of carbon nanotubes. ACS Nano. 2009;3:3707–3713.
   PubMed Web of Science ®Google Scholar
• Burke A, Ding X, Singh R, et al. Long-term survival following a single treatment of kidney tumors with multiwalled carbon nanotubes and near-infrared radiation. Proc Natl Acad Sci. 2009;106:12897–12902.
   PubMed Web of Science ®Google Scholar
• Hirsch LR, Stafford RJ, Bankson JA, et al. Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance. Proc Natl Acad Sci. 2003;100:13549–13554.
   PubMed Web of Science ®Google Scholar
• O'Neal DP, Hirsch LR, Halas NJ, et al. Photo-thermal tumor ablation in mice using near infrared-absorbing nanoparticles. Cancer Lett. 2004;209:171–176.
   PubMed Web of Science ®Google Scholar
• Cardinal J, Klune JR, Chory E, et al. Noninvasive radiofrequency ablation of cancer targeted by gold nanoparticles. Surgery. 2008;144:125–132.
   PubMed Web of Science ®Google Scholar
• Bernardi P, Cavagnaro M, Pisa S, et al. Specific absorption rate and temperature elevation in a subject exposed in the far-field of radio-frequency sources operating in the 10–900-MHz range. IEEE Trans Biomed Eng. 2003;50:295–304.
   PubMed Web of Science ®Google Scholar
• Cheng F-Y, Chen C-T, Yeh C-S. Comparative efficiencies of photothermal destruction of malignant cells using antibody-coated silica@ Au nanoshells, hollow Au/Ag nanospheres and Au nanorods. Nanotechnology. 2009;20:425104.
   PubMed Web of Science ®Google Scholar
• Huang YF, Sefah K, Bamrungsap S, et al. Selective photothermal therapy for mixed cancer cells using aptamer-conjugated nanorods. Langmuir. 2008;24:11860–11865.
   PubMed Web of Science ®Google Scholar
• Hu KW, Huang CC, Hwu JR, et al. A new photothermal therapeutic agent: core‐free nanostructured AuxAg1− x dendrites. Chem Eur J. 2008;14:2956–2964.
   PubMed Web of Science ®Google Scholar
• Hildebrand P, Kleemann M, Roblick UJ, et al. Radiofrequency-ablation of unresectable primary and secondary liver tumors: results in 88 patients. Langenbecks Arch Surg. 2006;391:118–123.
   PubMed Web of Science ®Google Scholar
• Witkamp AJ, de Bree E, Van Goethem R, et al. Rationale and techniques of intra-operative hyperthermic intraperitoneal chemotherapy. Cancer Treatment Rev. 2001;27:365–374.
   PubMed Web of Science ®Google Scholar
• Kossatz S, Grandke J, Couleaud, P, et al. Efficient treatment of breast cancer xenografts with multifunctionalized iron oxide nanoparticles combining magnetic hyperthermia and anti-cancer drug delivery. Breast Cancer Res. 2015;17:66.
   PubMed Web of Science ®Google Scholar
• Vernon C, Hand JW, Field SB, et al. Radiotherapy with or without hyperthermia in the treatment of superficial localized breast cancer: results from five randomized controlled trials. International Collaborative Hyperthermia Group. Int J Radiat Oncol Biol Phys. 1996;35:731–744.
   PubMed Web of Science ®Google Scholar
• Hildebrandt B, Wust P, Ahlers O, et al. The cellular and molecular basis of hyperthermia. Crit Rev Oncol Hematol. 2002;43:33–56.
   PubMed Web of Science ®Google Scholar
• van der Zee J, González González D, van Rhoon GC, et al. Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours: a prospective, randomised, multicentre trial. Lancet. 2000;355:1119–1125.
   PubMed Web of Science ®Google Scholar
• Diagaradjane P, Shetty A, Wang JC, et al. Modulation of in vivo tumor radiation response via gold nanoshell-mediated vascular-focused hyperthermia: characterizing an integrated antihypoxic and localized vascular disrupting targeting strategy. Nano Lett. 2008;8:1492–1500.
   PubMed Web of Science ®Google Scholar
• Atkinson RL, Zhang M, Diagaradjane P, et al. Thermal enhancement with optically activated gold nanoshells sensitizes breast cancer stem cells to radiation therapy. Sci Transl Med. 2010;2:55ra79.
   PubMed Web of Science ®Google Scholar
• Laurent S, Dutz S, Häfeli UO, et al. Magnetic fluid hyperthermia: focus on superparamagnetic iron oxide nanoparticles. Adv Colloid Interface Sci. 2011;166:8–23.
   PubMed Web of Science ®Google Scholar
• Orel V, Shevchenko A, Romanov A, et al. Magnetic properties and antitumor effect of nanocomplexes of iron oxide and doxorubicin. Nanomed: Nanotechnol Biol Med. 2015;11:47–55.
   PubMed Web of Science ®Google Scholar
• van Landeghem FKH, Maier-Hauff K, Jordan A, et al. Post-mortem studies in glioblastoma patients treated with thermotherapy using magnetic nanoparticles. Biomaterials. 2009;30:52–57.
   PubMed Web of Science ®Google Scholar
• Silva AC, Oliveira TR, Mamani JB, et al. Application of hyperthermia induced by superparamagnetic iron oxide nanoparticles in glioma treatment. Int J Nanomed. 2011;6:591–603.
   PubMed Web of Science ®Google Scholar
• Johannsen M, Thiesen B, Wust P, et al. Magnetic nanoparticle hyperthermia for prostate cancer. Int J Hypertherm. 2010;26:790–795.
   PubMed Web of Science ®Google Scholar
• Maier-Hauff K, Ulrich F, Nestler D, et al. Efficacy and safety of intratumoral thermotherapy using magnetic iron-oxide nanoparticles combined with external beam radiotherapy on patients with recurrent glioblastoma multiforme. J Neurooncol. 2011;103:317–324.
   PubMed Web of Science ®Google Scholar
• Kolosnjaj-Tabi J, Di Corato R, Lartigue L, et al. Heat-generating iron oxide nanocubes: subtle “destructurators” of the tumoral microenvironment. ACS Nano. 2014;8:4268–4283.
   PubMed Web of Science ®Google Scholar
• Bhattacharyya S, Kudgus, RA, Bhattacharya R, et al. Inorganic nanoparticles in cancer therapy. Pharm Res. 2011;28:237–259.
   PubMed Web of Science ®Google Scholar
• Bañobre-López M, Teijeiro A, Rivas J. Magnetic nanoparticle-based hyperthermia for cancer treatment. Rep Pract Oncol Radiother. 2013;18:397–400.
   PubMedGoogle Scholar
• Hilger I, Kaiser WA. Iron oxide-based nanostructures for MRI and magnetic hyperthermia. Nanomedicine (Lond). 2012;7:1443–1459.
   PubMed Web of Science ®Google Scholar
• Klein S, Sommer A, Distel LVR, et al. Superparamagnetic iron oxide nanoparticles as novel X-ray enhancer for low-dose radiation therapy. J Phys Chem B. 2014;118:6159–6166.
   PubMed Web of Science ®Google Scholar
• Kong T, Zeng J, Wang X, et al. Enhancement of radiation cytotoxicity in breast-cancer cells by localized attachment of gold nanoparticles. Small. 2008;4:1537–1543.
   PubMed Web of Science ®Google Scholar
• Huang X, Jain PK., El-Sayed IH, et al. Determination of the minimum temperature required for selective photothermal destruction of cancer cells with the use of immunotargeted gold nanoparticles. Photochem Photobiol. 2006;82:412–417.
   PubMed Web of Science ®Google Scholar
• Huang X, El-Sayed IH, Qian W, et al. Cancer cell imaging and photothermal therapy in the near-infrared region by using gold nanorods. J Am Chem Soc. 2006;128:2115–2120.
   PubMed Web of Science ®Google Scholar
• Huang X, El-Sayed IH, El-Sayed MA. Applications of gold nanorods for cancer imaging and photothermal therapy. Cancer nanotechnology: methods and protocols; 2010: 343–357.
   Google Scholar
• Sirotkina MA, Elagin VV, Shirmanova MV, et al. OCT-guided laser hyperthermia with passively tumor-targeted gold nanoparticles. J Biophotonics. 2010;3:718–727.
   PubMed Web of Science ®Google Scholar
• Chatterjee DK, Fong LS, Zhang Y. Nanoparticles in photodynamic therapy: an emerging paradigm. Adv Drug Deliv Rev. 2008;60:1627–1637.
   PubMed Web of Science ®Google Scholar
• Zhang A-P, Sun Y-P. Photocatalytic killing effect of TiO2 nanoparticles on Ls-174-t human colon carcinoma cells. WJG. 2004;10:3191–3193.
   PubMed Web of Science ®Google Scholar
• Thevenot P, Cho J, Wavhal D, et al. Surface chemistry influences cancer killing effect of TiO2 nanoparticles. Nanomed: Nanotechnol Biol Med. 2008;4:226–236.
   PubMed Web of Science ®Google Scholar
• Seo J-w, Chung H, Kim, M-y, et al. Development of water-soluble single-crystalline TiO2 nanoparticles for photocatalytic cancer-cell treatment. Small. 2007;3:850–853.
   PubMed Web of Science ®Google Scholar
• Hou Z, Zhang Y, Deng K, et al. UV-emitting upconversion-based TiO2 photosensitizing nanoplatform: near-infrared light mediated in vivo photodynamic therapy via mitochondria-involved apoptosis pathway. ACS Nano. 2015;9:2584–2599.
   PubMed Web of Science ®Google Scholar
• Wahab R, Dwivedi S, Umar A, et al. ZnO nanoparticles induce oxidative stress in Cloudman S91 melanoma cancer cells. J Biomed Nanotechnol. 2013;9:441–449.
   PubMed Web of Science ®Google Scholar
• Wahab R, Kaushik NK, Kaushik N, et al. ZnO nanoparticles induces cell death in malignant human T98G gliomas, KB and non-malignant HEK cells. J Biomed Nanotechnol. 2013;9:1181–1189.
   PubMed Web of Science ®Google Scholar
• Wahab R, Siddiqui MA, Saquib Q, et al. ZnO nanoparticles induced oxidative stress and apoptosis in HepG2 and MCF-7 cancer cells and their antibacterial activity. Colloids Surf B Biointerfaces. 2014;117:267–276.
   PubMed Web of Science ®Google Scholar
• Ryter SW, Kim HP, Hoetzel A, et al. Mechanisms of cell death in oxidative stress. Antioxid Redox Signal. 2007;9:49–89.
   PubMed Web of Science ®Google Scholar
• Baskar G, Chandhuru J, Sheraz Fahad K, et al. Anticancer activity of fungal l-asparaginase conjugated with zinc oxide nanoparticles. J Mater Sci: Mater Med. 2015;26:1–7.
   Web of Science ®Google Scholar
• Wason, MS, Colon J, Das, S, et al. Sensitization of pancreatic cancer cells to radiation by cerium oxide nanoparticle-induced ROS production. Nanomed: Nanotechnol Biol Med. 2013;9:558–569.
   PubMed Web of Science ®Google Scholar
• Colon J, Hsieh N, Ferguson A, et al. Cerium oxide nanoparticles protect gastrointestinal epithelium from radiation-induced damage by reduction of reactive oxygen species and upregulation of superoxide dismutase 2. Nanomed: Nanotechnol Biol Med. 2010;6:698–705.
   PubMed Web of Science ®Google Scholar
• Tarnuzzer RW, Colon J, Patil S, et al. Vacancy engineered ceria nanostructures for protection from radiation-induced cellular damage. Nano Lett. 2005;5:2573–2577.
   PubMed Web of Science ®Google Scholar
• Neri D, Supuran CT. Interfering with pH regulation in tumours as a therapeutic strategy. Nat Rev Drug Discov. 2011;10:767–777.
   PubMed Web of Science ®Google Scholar
• Ali D, Alarifi S, Alkahtani S, et al. Cerium oxide nanoparticles induce oxidative stress and genotoxicity in human skin melanoma cells. Cell Biochem Biophys. 2015;71:1643–1651.
   PubMed Web of Science ®Google Scholar
• Pešić M, Podolski-Renić A, Stojković S, et al. Anti-cancer effects of cerium oxide nanoparticles and its intracellular redox activity. Chem-Biol Interact. 2015;232:85–93.
   PubMed Web of Science ®Google Scholar
• Franco-Molina MA, Mendoza-Gamboa E, Sierra-Rivera CA, et al. Antitumor activity of colloidal silver on MCF-7 human breast cancer cells. J Exp Clin Cancer Res. 2010;29:148.
   PubMed Web of Science ®Google Scholar
• Shvedova A, Castranova V, Kisin E, et al. Exposure to carbon nanotube material: assessment of nanotube cytotoxicity using human keratinocyte cells. J Toxicol Environ Health A. 2003;66:1909–1926.
   PubMed Web of Science ®Google Scholar
• Xu R, Ma J, Sun X, et al. Ag nanoparticles sensitize IR-induced killing of cancer cells. Cell Res. 2009;19:1031.
   PubMed Web of Science ®Google Scholar
• Meng H, Wang, M, Liu H, et al. Use of a lipid-coated mesoporous silica nanoparticle platform for synergistic gemcitabine and paclitaxel delivery to human pancreatic cancer in mice. ACS Nano. 2015;9:3540–3557.
   PubMed Web of Science ®Google Scholar
• Bagwe RP, Hilliard LR, Tan W. Surface modification of silica nanoparticles to reduce aggregation and nonspecific binding. Langmuir. 2006;22:4357–4362.
   PubMed Web of Science ®Google Scholar
• Wang Y, Yang F, Zhang H-X, et al. Cuprous oxide nanoparticles inhibit the growth and metastasis of melanoma by targeting mitochondria. Cell Death Dis. 2013;4:e783.
   PubMed Web of Science ®Google Scholar
• Melancon MP, Lu W, Zhong M, et al. Targeted multifunctional gold-based nanoshells for magnetic resonance-guided laser ablation of head and neck cancer. Biomaterials. 2011;32:7600–7608.
   PubMed Web of Science ®Google Scholar
• Rivera Gil P, Hühn D, del Mercato LL, et al. Nanopharmacy: inorganic nanoscale devices as vectors and active compounds. Pharmacol Res. 2010;62:115–125.
   PubMed Web of Science ®Google Scholar
• Johannsen M, Gneveckow U, Taymoorian K, et al. Morbidity and quality of life during thermotherapy using magnetic nanoparticles in locally recurrent prostate cancer: results of a prospective phase I trial. Int J Hypertherm. 2007;23:315–323.
   PubMed Web of Science ®Google Scholar
• Anselmo AC, Mitragotri S. A review of clinical translation of inorganic nanoparticles. AAPS J. 2015;17:1041–1054.
   PubMed Web of Science ®Google Scholar
• Kim J-K, Seo SJ, Kim KH, et al. Therapeutic application of metallic nanoparticles combined with particle-induced X-ray emission effect. Nanotechnology. 2010;21:425102.
   PubMed Web of Science ®Google Scholar
• Ventola CL. The nanomedicine revolution: part 2: current and future clinical applications. Pharm Ther. 2012;37:582.
   Google Scholar
• Thakor AS, Luong R, Paulmurugan R, et al. The fate and toxicity of Raman-active silica-gold nanoparticles in mice. Sci Transl Med. 2011;3:79ra33.
   PubMed Web of Science ®Google Scholar
• Gad SC, Sharp KL, Montgomery C, et al. Evaluation of the toxicity of intravenous delivery of auroshell particles (gold–silica nanoshells). Int J Toxicol. 2012;31:584–594.
   PubMed Web of Science ®Google Scholar
• Roa W, Xiong Y, Chen J, et al. Pharmacokinetic and toxicological evaluation of multi-functional thiol-6-fluoro-6-deoxy-d-glucose gold nanoparticles in vivo. Nanotechnology. 2012;23:375101.
   PubMed Web of Science ®Google Scholar
• Cho SH, Jones BL, Krishnan S. The dosimetric feasibility of gold nanoparticle-aided radiation therapy (GNRT) via brachytherapy using low-energy gamma-/X-ray sources. Phys Med Biol. 2009;54:4889.
   PubMed Web of Science ®Google Scholar
• Joh DY, Sun L, Stangl M, et al. Selective targeting of brain tumors with gold nanoparticle-induced radiosensitization. PLoS One. 2013;8:e62425.
   PubMed Web of Science ®Google Scholar
• Herold M, Das IJ, Stobbe CC. Gold microspheres: a selective technique for producing biologically effective dose enhancement. Int J Radiat Biol. 2000;76:1357–1364.
   PubMed Web of Science ®Google Scholar
• Roa W, Zhang X, Guo L, et al. Gold nanoparticle sensitize radiotherapy of prostate cancer cells by regulation of the cell cycle. Nanotechnology. 2009;20:375101.
   PubMed Web of Science ®Google Scholar
• Hainfeld, JF, Foley CJ, Srivastava SC, et al. Radioactive gold cluster immunoconjugates: potential agents for cancer therapy. Int J Radiat Appl Instrum B: Nucl Med Biol. 1990;17:287–294.
   PubMedGoogle Scholar
• Cho SH. Estimation of tumour dose enhancement due to gold nanoparticles during typical radiation treatments: a preliminary Monte Carlo study. Phys Med Biol. 2005;50:N163.
   PubMed Web of Science ®Google Scholar
• Benezra M, Penate-Medina O, Zanzonico PB, et al. Multimodal silica nanoparticles are effective cancer-targeted probes in a model of human melanoma. J Clin Invest. 2011;121:2768–2780.
   PubMed Web of Science ®Google Scholar
• Kim J, Park S, Lee JE, et al. Designed fabrication of multifunctional magnetic gold nanoshells and their application to magnetic resonance imaging and photothermal therapy. Angew Chem. 2006;118:7918–7922.
   Google Scholar
• Pattani VP, Tunnell JW. Nanoparticle‐mediated photothermal therapy: a comparative study of heating for different particle types. Lasers Surg Med. 2012;44:675–684.
   PubMed Web of Science ®Google Scholar
• Loo C, Lowery A, Halas N, et al. Immunotargeted nanoshells for integrated cancer imaging and therapy. Nano Lett. 2005;5:709–711.
   PubMed Web of Science ®Google Scholar
• Choi M-R, Bardhan R, Stanton-Maxey KJ, et al. Delivery of nanoparticles to brain metastases of breast cancer using a cellular Trojan horse. Cancer Nano. 2012;3:47–54.
   PubMedGoogle Scholar
• Kleinauskas A, Rocha S, Sahu S, et al. Carbon-core silver-shell nanodots as sensitizers for phototherapy and radiotherapy. Nanotechnology. 2013;24:325103.
   PubMed Web of Science ®Google Scholar
• Locatelli E, Naddaka M, Uboldi C, et al. Targeted delivery of silver nanoparticles and alisertib: in vitro and in vivo synergistic effect against glioblastoma. Nanomedicine. 2014;9:839–849.
   PubMed Web of Science ®Google Scholar
• Gehrke H, Pelka J, Hartinger CG, et al. Platinum nanoparticles and their cellular uptake and DNA platination at non-cytotoxic concentrations. Arch Toxicol. 2011;85:799–812.
   PubMed Web of Science ®Google Scholar
• Pelka J, Gehrke H, Esselen M, et al. Cellular uptake of platinum nanoparticles in human colon carcinoma cells and their impact on cellular redox systems and DNA integrity. Chem Res Toxicol. 2009;22:649–659.
   PubMed Web of Science ®Google Scholar
• Holford J, Raynaud F, Murrer BA, et al. Chemical, biochemical and pharmacological activity of the novel sterically hindered platinum co-ordination complex, cis-[amminedichloro (2-methylpyridine)] platinum (II)(AMD473). Anti-Cancer Drug Des. 1998;13:1–18.
   PubMedGoogle Scholar
• Raynaud FI, Boxall FE, Goddard PM, et al. cis-Amminedichloro (2-methylpyridine) platinum (II)(AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice. Clin Cancer Res. 1997;3:2063–2074.
   PubMed Web of Science ®Google Scholar
• Holford J, Sharp SY, Murrer, BA, et al. In vitro circumvention of cisplatin resistance by the novel sterically hindered platinum complex AMD473. Br J Cancer. 1998;77:366.
   PubMed Web of Science ®Google Scholar
• Wong E, Giandomenico CM. Current status of platinum-based antitumor drugs. Chem Rev. 1999;99:2451–2466.
   PubMed Web of Science ®Google Scholar
• Knox RJ, Friedlos F, Lydall DA, et al. Mechanism of cytotoxicity of anticancer platinum drugs: evidence that cis-diamminedichloroplatinum (II) and cis-diammine-(1, 1-cyclobutanedicarboxylato) platinum (II) differ only in the kinetics of their interaction with DNA. Cancer Res. 1986;46(4 Part 2):1972–1979.
   Web of Science ®Google Scholar
• Rosenberg B, Renshaw E, Vancamp L, et al. Platinum-induced filamentous growth in Escherichia coli. J Bacteriol. 1967;93:716–721.
   PubMed Web of Science ®Google Scholar
• Lebwohl D, Canetta R. Clinical development of platinum complexes in cancer therapy: an historical perspective and an update. Eur J Cancer. 1998;34:1522–1534.
   PubMed Web of Science ®Google Scholar
• Asharani PV, Xinyi Ng, Hande MP, et al. DNA damage and p53-mediated growth arrest in human cells treated with platinum nanoparticles. Nanomedicine. 2010;5:51–64.
   PubMed Web of Science ®Google Scholar
• Wu Q, Qin S-K, Teng F-M, et al. Lobaplatin arrests cell cycle progression in human hepatocellular carcinoma cells. J Hematol Oncol. 2010;3:43.
   PubMed Web of Science ®Google Scholar
• Drees M, Dengler WM, Hendriks HR, et al. Cycloplatam: a novel platinum compound exhibiting a different spectrum of anti-tumour activity to cisplatin. Eur J Cancer. 1995;31:356–361.
   Google Scholar
• Kelland LR, Mistry P, Abel G, et al. Establishment and characterization of an in vitro model of acquired resistance to cisplatin in a human testicular nonseminomatous germ cell line. Cancer Res. 1992;52:1710–1716.
   PubMed Web of Science ®Google Scholar
• Kraker A, et al. Preclinical characterization of the in vitro and in vivo activity of [1, 1′-cyclobutanedicarboxylato (2-)-0,0′](2-methyl-1, 4-butanediamine-n, n′) pt (nk-121/ci-973). Proceedings of the American Association for Cancer Research; 1988; Philadelphia, PA.
   Google Scholar
• Fujiwara R, Luo Y, Sasaki T, et al. Cancer therapeutic effects of titanium dioxide nanoparticles are associated with oxidative stress and cytokine induction. Pathobiology. 2015;82:243–251.
   PubMed Web of Science ®Google Scholar
• Chakraborty R, Basu T. Metallic copper nanoparticle induces apoptosis in human skin melanoma, A-375 cell line. Nanotechnology. 2017;28:105101.
   PubMed Web of Science ®Google Scholar
• Kamble S, Utage B, Mogle P, et al. Evaluation of curcumin capped copper nanoparticles as possible inhibitors of human breast cancer cells and angiogenesis: a comparative study with native curcumin. AAPS PharmSciTech. 2016;17:1030–1041.
   PubMed Web of Science ®Google Scholar
• Giri S, Karakoti A, Graham, RP, et al. Nanoceria: a rare-earth nanoparticle as a novel anti-angiogenic therapeutic agent in ovarian cancer. PLoS One. 2013;8:e54578.
   PubMed Web of Science ®Google Scholar
• Lin W, Huang Y-W, Zhou X-D, et al. Toxicity of cerium oxide nanoparticles in human lung cancer cells. Int J Toxicol. 2006;25:451–457.
   PubMed Web of Science ®Google Scholar
• Namvar F, Rahman HS, Mohamad R, et al. Cytotoxic effects of biosynthesized zinc oxide nanoparticles on murine cell lines. Evid-Based Complement Alternat Med. 2015;2015:593014.
   PubMed Web of Science ®Google Scholar